Skokie Hospital Opens a New Spine Center Reports NorthShore University HealthSystem

Skokie Hospital has opened a new spine center. The news was announced today by NorthShore University HealthSystem.

The new spine center at Skokie Hospital will treat patients with back and neck conditions, some of the most common causes of pain and disability in the United States.

Part of the NorthShore Orthopaedic & Spine Institute, this innovative space brings together a multidisciplinary, collaborative team of specialists including orthopaedic surgery, neurosurgery, physical medicine and rehabilitation, anesthesia, physical therapy, integrative medicine and pain psychology to conservatively treat complex spine conditions.

“We’re thrilled to open this dedicated space where our expert physicians and care teams work together to offer the best, personalized care to help the growing number of people challenged with spine conditions or complex back issues,” said Skokie Hospital President David Rahija. “Many of our physicians are nationally recognized in their specialties and treat patients from the entire region including professional and college athletes. We are proud to offer their expertise to the entire community.”

The NorthShore Spine Center offers a full range of treatment options, from physical therapy to integrative medicine treatments, including massage therapy and acupuncture, to the most advanced minimally invasive and computer- and robot-assisted surgical procedures and motion preservation techniques.

To enhance and support the Spine Center’s mission to help patients return to pain-free living, NorthShore has also opened the NorthShore Integrated Pain Center at Skokie Hospital to treat complex pain conditions using the most advanced interventional pain procedures.

In 2019, the NorthShore Orthopaedic & Spine Institute became Illinois’ first hospital dedicated to orthopaedic and spine care.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”